PL359623A1 - Miejscowo działające preparaty zawiesinowe zawierające ciprofloksacynę i deksametazon - Google Patents

Miejscowo działające preparaty zawiesinowe zawierające ciprofloksacynę i deksametazon

Info

Publication number: PL359623A1
Authority: PL; Poland
Prior art keywords: dexamethasone; formulations containing; suspension formulations; topical suspension; containing ciprofloxacin
Prior art date: 1999-09-24

Application number

PL00359623A

Other languages

English (en)

Other versions

PL201130B1 (pl

Inventor

Onkar N. Singh

Haresh G. Bhagat

Original Assignee

Alcon Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-24

Filing date

2000-08-10

Publication date

2004-08-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22557406&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL359623(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-08-10 Application filed by Alcon Inc. filed Critical Alcon Inc.

2004-08-23 Publication of PL359623A1 publication Critical patent/PL359623A1/pl

2009-03-31 Publication of PL201130B1 publication Critical patent/PL201130B1/pl

Links

NTRHYMXQWWPZDD-WKSAPEMMSA-N 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;(8s,9r,10s,11s,13s,14s,16r,17r)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1.C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NTRHYMXQWWPZDD-WKSAPEMMSA-N 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
229940061102 topical suspension Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Ophthalmology & Optometry (AREA)
Otolaryngology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Dispersion Chemistry (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

PL359623A 1999-09-24 2000-08-10 Kompozycje zawiesinowe zawierające ciprofloksacynę i deksametazon do podawania miejscowego do oczu, uszu lub nosa PL201130B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US15594299P	1999-09-24	1999-09-24
PCT/US2000/021961 WO2001022936A1 (en)	1999-09-24	2000-08-10	Topical suspension formulations containing ciprofloxacin and dexamethasone

Publications (2)

Publication Number	Publication Date
PL359623A1 true PL359623A1 (pl)	2004-08-23
PL201130B1 PL201130B1 (pl)	2009-03-31

Family

ID=22557406

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL359623A PL201130B1 (pl)	1999-09-24	2000-08-10	Kompozycje zawiesinowe zawierające ciprofloksacynę i deksametazon do podawania miejscowego do oczu, uszu lub nosa

Country Status (22)

Country	Link
US (2)	US6284804B1 (pl)
EP (1)	EP1214056B1 (pl)
JP (2)	JP2003510263A (pl)
KR (1)	KR100722502B1 (pl)
CN (1)	CN1158994C (pl)
AR (1)	AR025661A1 (pl)
AT (1)	ATE252887T1 (pl)
AU (1)	AU776609B2 (pl)
BR (1)	BR0014203A (pl)
CA (1)	CA2379605C (pl)
DE (1)	DE60006262T2 (pl)
DK (1)	DK1214056T3 (pl)
ES (1)	ES2207549T3 (pl)
HK (1)	HK1045653B (pl)
MX (1)	MXPA02003130A (pl)
PL (1)	PL201130B1 (pl)
PT (1)	PT1214056E (pl)
SA (1)	SA00210418B1 (pl)
TR (1)	TR200200737T2 (pl)
TW (1)	TWI228423B (pl)
WO (1)	WO2001022936A1 (pl)
ZA (1)	ZA200201904B (pl)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003510263A (ja) *	1999-09-24	2003-03-18	アルコン，インコーポレイテッド	シプロフロキサシンおよびデキサメタゾンを含有する局所用懸濁処方物
ATE424808T1 (de) *	2000-11-15	2009-03-15	Chandavarkar Mohan A	Pharmazeutische zusammensetzungen mit corticosteroiden und antiinfektiva
WO2003004098A1 (en) *	2001-07-06	2003-01-16	Sucampo Ag	Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent
CN1231218C (zh) *	2001-09-21	2005-12-14	爱尔康公司	药物组合物在制备用于治疗中耳感染的药物中的用途
US20090215735A1 (en) *	2002-02-25	2009-08-27	Alcon, Inc.	Topical solution formulations containing a corticosteroid and a cyclodextrin
AU2003223214B2 (en) *	2002-03-01	2008-09-18	Celltech R & D, Inc.	Methods to increase or decrease bone density
AU2003280960A1 (en) *	2002-07-15	2004-02-02	Alcon, Inc.	Pharmaceutical compositions for otic use
US20040101506A1 (en) *	2002-11-25	2004-05-27	Fust Charles A.	Composition for the prevention and treatment of inflammation of the ear
US7220431B2 (en) *	2002-11-27	2007-05-22	Regents Of The University Of Minnesota	Methods and compositions for applying pharmacologic agents to the ear
TWI335819B (en) *	2002-12-24	2011-01-11	Alcon Inc	Use of oculosurface selective glucocorticoid in the treatment of dry eye
EP1596823A2 (en) *	2003-02-21	2005-11-23	Sun Pharmaceuticals Industries Ltd.	A stable ophthalmic composition
US20040202687A1 (en) *	2003-04-14	2004-10-14	Babu M.K. Manoj	Ciprofloxacin formulations and methods of making and using the same
US20050085446A1 (en) *	2003-04-14	2005-04-21	Babu M.K. M.	Fluoroquinolone formulations and methods of making and using the same
EP1627637A1 (en) *	2003-05-23	2006-02-22	Santen Pharmaceutical Co., Ltd.	Ophthalmic solution containing quinolone antimicrobial compound
CA2548892C (en)	2003-12-12	2015-10-27	Eran Eilat	Compositions for treatment of ear disorders and methods of use thereof
US8940321B2 (en) *	2003-12-12	2015-01-27	Otic Pharma Ltd.	Compositions for treatment of ear disorders and methods of use thereof
ES2245611B1 (es) *	2004-06-29	2007-03-16	Laboratorio Reig Jofre, S.A.	Composicion farmaceutica para uso ototopico.
US20060019987A1 (en) *	2004-07-23	2006-01-26	Fust Charles A	Methods and compositions for inhibiting, destroying, and/or inactivating viruses
DE102006010643A1 (de)	2006-03-08	2007-09-13	Bayer Healthcare Aktiengesellschaft	Arzneimittel enthaltend Fluorchinolone
US20070264296A1 (en) *	2006-05-10	2007-11-15	Myntti Matthew F	Biofilm extracellular polysachharide solvating system
US7993675B2 (en) *	2006-05-10	2011-08-09	Medtronic Xomed, Inc.	Solvating system and sealant for medical use in the sinuses and nasal passages
US7976873B2 (en) *	2006-05-10	2011-07-12	Medtronic Xomed, Inc.	Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US7959943B2 (en) *	2006-05-10	2011-06-14	Medtronics Xomed, Inc.	Solvating system and sealant for medical use in the middle or inner ear
WO2008035246A2 (en)	2006-07-28	2008-03-27	Novagali Pharma Sa	Compositions containing quaternary ammonium compounds
US8088095B2 (en) *	2007-02-08	2012-01-03	Medtronic Xomed, Inc.	Polymeric sealant for medical use
CN101317847B (zh) *	2007-06-06	2010-10-13	深圳市瑞谷医药技术有限公司	一种眼用或耳鼻用药物组合物及其用途
US8271101B2 (en) *	2007-08-29	2012-09-18	Advanced Bionics	Modular drug delivery system for minimizing trauma during and after insertion of a cochlear lead
JP4696251B2 (ja) *	2007-12-28	2011-06-08	防衛省技術研究本部長	多剤耐性緑膿菌の単離方法並びに多剤耐性緑膿菌選択培地の作成方法
CN101970042A (zh)	2008-02-25	2011-02-09	眼门药品公司	经由离子电渗法增强递送治疗药物至眼部组织
US8030297B2 (en)	2008-05-14	2011-10-04	Otonomy, Inc.	Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders
ES2759373T3 (es)	2008-06-12	2020-05-08	Medtronic Xomed Inc	Producto para el tratamiento de heridas crónicas con un sistema extracelular de solvatación de sustancias poliméricas
US20110117189A1 (en) *	2008-07-08	2011-05-19	S.I.F.I. Societa' Industria Farmaceutica Italiana S.P.A.	Ophthalmic compositions for treating pathologies of the posterior segment of the eye
US8318817B2 (en) *	2008-07-21	2012-11-27	Otonomy, Inc.	Controlled release antimicrobial compositions and methods for the treatment of otic disorders
US20100016450A1 (en) *	2008-07-21	2010-01-21	Otonomy, Inc.	Controlled release delivery devices for the treatment of otic disorders
WO2010042427A2 (en) *	2008-10-06	2010-04-15	Microbial Defense Systems, Llc	Antimicrobial composition and methods of making and using same
TW201023912A (en) *	2008-12-05	2010-07-01	Alcon Res Ltd	Pharmaceutical suspension
AU2010221438C1 (en) *	2009-03-03	2015-01-29	Alcon Research, Ltd.	Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye
US8912236B2 (en) *	2009-03-03	2014-12-16	Alcon Research, Ltd.	Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye
EP2490722A4 (en) *	2009-10-21	2014-03-05	Otonomy Inc	MODULATION OF THE TEMPERATURE OF GELIFICATION OF FORMULATIONS CONTAINING POLOXAMERS
EP2366408B1 (en) *	2010-03-01	2012-07-18	Laboratorios SALVAT, S.A.	Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation
US8916171B2 (en)	2010-04-27	2014-12-23	Topical Sinus Therapeutics, Inc.	Topical delivery of viscous medications for the treatment of diseases associated with chronic sinusitis
AU2012253476B2 (en)	2011-05-10	2015-09-24	Next Science IP Holdings Pty Ltd	Antimicrobial solid and methods of making and using same
BR112014013564A8 (pt) *	2011-12-09	2017-06-13	Lupin Ltd	composição farmacêutica tópica destinada à aplicação ao olho, ouvido ou nariz
CN103565816A (zh) *	2012-07-25	2014-02-12	天津金耀集团有限公司	妥布霉素地塞米松滴眼液
EP2938327B1 (en)	2012-12-26	2017-12-06	Otic Pharma Ltd.	Foamable otic pharmaceutical compositions
US20150164882A1 (en)	2013-07-22	2015-06-18	Imprimis Pharmaceuticals, Inc.	Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
US20160279055A1 (en)	2013-07-22	2016-09-29	Imprimis Pharmaceuticals, Inc.	Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
JP2016534121A (ja)	2013-08-27	2016-11-04	オトノミ—，インク．	小児の耳の病気の処置
US20150119371A1 (en) *	2013-10-30	2015-04-30	Micro Labs Limited	Topical pharmaceutical compositions of antibiotics and steroidal anti inflammatory agents
WO2016004231A1 (en)	2014-07-03	2016-01-07	Otonomy, Inc.	Sterilization of ciprofloxacin composition
US9393243B1 (en) *	2015-07-14	2016-07-19	Nilesh Parikh	Topical Ciprofloxacin compositions
CA3023243C (en) *	2016-05-06	2020-01-21	Imprimis Pharmaceuticals, Inc.	Pharmaceutical ophthalmic compositions and methods for fabricating thereof
KR102395835B1 (ko) *	2016-08-24	2022-05-10	키에시 파르마슈티시 엣스. 피. 에이.	재구성된 폐 계면활성제 조성물을 포함하는 안정한 약제학적 제제
EP3512513A4 (en)	2016-09-16	2020-04-15	Otonomy, Inc.	OTIC GEL FORMULATIONS FOR THE TREATMENT OF EXTERNAL OTITIS
CN107970244B (zh) *	2016-10-21	2020-07-14	武汉武药科技有限公司	一种含有环丙沙星和地塞米松的组合物及其制备方法
CN108403700A (zh) *	2018-06-12	2018-08-17	新疆生产建设兵团第师畜牧兽医工作站	一种牛呼吸道疾病治疗用复合注射液
JP6994061B2 (ja) *	2019-02-15	2022-01-14	ノバルティスアーゲー	４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの製剤
CN113797164B (zh) *	2020-06-17	2023-07-14	成都瑞沐生物医药科技有限公司	一种眼用制剂的载体或辅料及其制备方法和应用
CN113144207A (zh) *	2021-02-07	2021-07-23	山西利普达医药科技有限公司	一种包括聚季铵盐-1的组合物及其应用
US12023344B2 (en)	2022-05-25	2024-07-02	Famygen Life Sciences, Inc.	Topical otic, ophthalmic, and nasal corticosteroid formulations
KR102927998B1 (ko) *	2022-12-09	2026-02-20	가톨릭대학교 산학협력단	약물　전달용 조성물 및 이의 용도

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3134718A (en)	1963-12-12	1964-05-26	Schering Corp	Pregna-1,4-dienes and compositions containing same
US4670444B1 (en)	1980-09-03	1999-02-09	Bayer Ag	and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
US5223493A (en)	1984-12-28	1993-06-29	Alcon Laboratories, Inc.	Anti-inflammatory compounds for ophthalmic use
US4686214A (en)	1985-10-30	1987-08-11	Alcon Laboratories, Inc.	Anti-inflammatory compounds for ophthalmic use
DE3704907A1 (de)	1987-02-17	1988-08-25	Bayer Ag	Topisch anwendbare zubereitungen von gyrase-inhibitoren in kombination mit kortikosteroiden
GB8805268D0 (en) *	1988-03-04	1988-04-07	Glaxo Group Ltd	Medicaments
WO1990001933A1 (en) *	1988-08-26	1990-03-08	Alcon Laboratories, Inc.	Combination of quinolone antibiotics and steroids for topical ophthalmic use
AU2672892A (en)	1991-09-17	1993-04-27	Alcon Laboratories, Inc.	Compositions containing quinolone antibiotics and sulfonate of polystyrol
ES2065846B1 (es) *	1993-04-20	1995-10-01	Cusi Lab	Formulacion farmaceutica a base de un agente antiinflamatorio esteroidico o no esteroidico y un antibiotico pertenciente al grupo de los inhibidores de la adn girasa para su utilizacion topica oftalmica.
US5540930A (en)	1993-10-25	1996-07-30	Pharmos Corporation	Suspension of loteprednol etabonate for ear, eye, or nose treatment
US5420120A (en)	1993-12-17	1995-05-30	Alcon Laboratories, Inc.	Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
JP3781792B2 (ja) *	1993-12-27	2006-05-31	千寿製薬株式会社	ジフルプレドナート含有点眼用懸濁液剤
ES2078175B1 (es)	1993-12-31	1996-10-16	Cusi Lab	Formulacion farmaceutica conteniendo clobetasona y tobramicina y sus aplicaciones.
US5422116A (en) *	1994-02-18	1995-06-06	Ciba-Geigy Corporation	Liquid ophthalmic sustained release delivery system
US5843930A (en)	1995-06-06	1998-12-01	Bayer Corporation	Method of treating otitis with ciprofloxacin-hydrocortisone suspension
DE19524691A1 (de)	1995-07-06	1997-01-09	Liedtke Pharmed Gmbh	Methode und Zusammensetzung einer topischen Therapie von Innenohr und Labyrinth-Symptomen
KR0155950B1 (ko)	1995-08-16	1998-12-01	김광호	플라즈마 확산 제어 방법 및 그 장치
KR100508227B1 (ko)	1997-03-14	2006-03-23	센주 세이야꾸 가부시키가이샤	로테프레드놀에타보네이트수성현탁액
AR020660A1 (es)	1998-09-30	2002-05-22	Alcon Lab Inc	Composiciones antibioticas para el tratamiento de ojos, oidos y nariz
WO2000018404A1 (en)	1998-09-30	2000-04-06	Alcon Laboratories, Inc.	Antibiotic compositions for treatment of the eye, ear and nose
AR020661A1 (es)	1998-09-30	2002-05-22	Alcon Lab Inc	Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
US6395746B1 (en)	1998-09-30	2002-05-28	Alcon Manufacturing, Ltd.	Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
JP2003510263A (ja) *	1999-09-24	2003-03-18	アルコン，インコーポレイテッド	シプロフロキサシンおよびデキサメタゾンを含有する局所用懸濁処方物

2000
- 2000-08-10 JP JP2001526148A patent/JP2003510263A/ja active Pending
- 2000-08-10 TR TR2002/00737T patent/TR200200737T2/xx unknown
- 2000-08-10 DE DE60006262T patent/DE60006262T2/de not_active Expired - Lifetime
- 2000-08-10 AT AT00959213T patent/ATE252887T1/de active
- 2000-08-10 ES ES00959213T patent/ES2207549T3/es not_active Expired - Lifetime
- 2000-08-10 US US09/636,563 patent/US6284804B1/en not_active Expired - Lifetime
- 2000-08-10 EP EP00959213A patent/EP1214056B1/en not_active Expired - Lifetime
- 2000-08-10 AU AU70570/00A patent/AU776609B2/en not_active Expired
- 2000-08-10 KR KR1020027003205A patent/KR100722502B1/ko not_active Expired - Lifetime
- 2000-08-10 PL PL359623A patent/PL201130B1/pl unknown
- 2000-08-10 CA CA002379605A patent/CA2379605C/en not_active Expired - Lifetime
- 2000-08-10 CN CNB008132623A patent/CN1158994C/zh not_active Expired - Lifetime
- 2000-08-10 DK DK00959213T patent/DK1214056T3/da active
- 2000-08-10 BR BR0014203-4A patent/BR0014203A/pt not_active Application Discontinuation
- 2000-08-10 HK HK02107186.7A patent/HK1045653B/en not_active IP Right Cessation
- 2000-08-10 MX MXPA02003130A patent/MXPA02003130A/es active IP Right Grant
- 2000-08-10 WO PCT/US2000/021961 patent/WO2001022936A1/en not_active Ceased
- 2000-08-10 PT PT00959213T patent/PT1214056E/pt unknown
- 2000-08-28 TW TW089117377A patent/TWI228423B/zh not_active IP Right Cessation
- 2000-09-14 AR ARP000104822A patent/AR025661A1/es unknown
- 2000-10-03 SA SA00210418A patent/SA00210418B1/ar unknown
2001
- 2001-05-25 US US09/865,783 patent/US6359016B2/en not_active Expired - Lifetime
2002
- 2002-03-07 ZA ZA200201904A patent/ZA200201904B/en unknown
2010
- 2010-11-18 JP JP2010258386A patent/JP2011032293A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
HK1045653B (en)	2004-01-30
MXPA02003130A (es)	2004-04-21
SA00210418B1 (ar)	2006-04-22
BR0014203A (pt)	2002-05-21
ZA200201904B (en)	2003-05-28
DE60006262T2 (de)	2004-05-13
CA2379605C (en)	2007-06-26
DE60006262D1 (de)	2003-12-04
JP2011032293A (ja)	2011-02-17
CN1158994C (zh)	2004-07-28
WO2001022936A8 (en)	2002-01-24
ATE252887T1 (de)	2003-11-15
JP2003510263A (ja)	2003-03-18
US20010034339A1 (en)	2001-10-25
HK1045653A1 (en)	2002-12-06
AR025661A1 (es)	2002-12-11
TR200200737T2 (tr)	2002-08-21
KR20020069508A (ko)	2002-09-04
US6284804B1 (en)	2001-09-04
EP1214056B1 (en)	2003-10-29
US6359016B2 (en)	2002-03-19
DK1214056T3 (da)	2004-02-09
ES2207549T3 (es)	2004-06-01
EP1214056A1 (en)	2002-06-19
TWI228423B (en)	2005-03-01
CN1376054A (zh)	2002-10-23
PT1214056E (pt)	2004-02-27
AU7057000A (en)	2001-04-30
AU776609B2 (en)	2004-09-16
CA2379605A1 (en)	2001-04-05
PL201130B1 (pl)	2009-03-31
WO2001022936A1 (en)	2001-04-05
KR100722502B1 (ko)	2007-05-28

Publication	Publication Date	Title
PL359623A1 (pl)	2004-08-23	Miejscowo działające preparaty zawiesinowe zawierające ciprofloksacynę i deksametazon
EG24066A (en)	2008-05-08	Novel quinuclidine derivatives and medicinal compositions containing the same
IL147296A0 (en)	2002-08-14	Imidazoimidazoles and triazoles as anti-inflammatory agents
IL190220A0 (en)	2008-11-03	Novel composition and use
AU5326100A (en)	2000-12-28	Pharmaceutical compositions and methods for use
EP1194147A4 (en)	2002-10-09	DERIVATIVES OF ARYLTHIAZOLIDINEDIONE AND ARYLOXAZOLIDINEDIONE
EG22674A (en)	2003-06-30	Ectroparasiticidal aquequs suspension formulations
HUP0203896A3 (en)	2003-05-28	Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
GB9815532D0 (en)	1998-09-16	Pharmaceutical suspension formulation
HU0001396D0 (en)	2000-06-28	3-amino-3-arylpropan-1-al derivatives and their use
EG22491A (en)	2003-03-31	Rest-breaking composition and use thereof
GB2346237B (en)	2003-04-30	Dynamic voltage sense amplifier
EP1229913A4 (en)	2005-01-19	SUBSTITUTED 1-BENZAZEPINE AND THEIR DERIVATIVES
AU6891800A (en)	2001-04-10	Flint analog compounds and formulations thereof
AU7308300A (en)	2001-05-10	Agents for reducing cholesterol-uptake and liquid-uptake
AU5974100A (en)	2001-01-31	6-carboxyphenyldihydropyridazinone derivatives and use thereof
AU5931300A (en)	2001-01-30	Ringene compositions and methods for use thereof
AU7053000A (en)	2001-04-10	Flint compounds and formulations thereof
AU6150400A (en)	2001-01-31	Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and use thereof
GB9911606D0 (en)	1999-07-21	Composition and use
AU7053100A (en)	2001-04-10	Flint analog compounds and formulations thereof
EG24062A (en)	2008-05-08	Novel composition and use
TW428884U (en)	2001-04-01	Improved structure of the pivot axle
GB9916506D0 (en)	1999-09-15	Compositions and methods
GB9902051D0 (en)	1999-03-17	Compositions and methods